67 related articles for article (PubMed ID: 33029523)
1. EphB3 receptor suppressor invasion, migration and proliferation in glioma by inhibiting EGFR-PI3K/AKT signaling pathway.
Xiao Z; Huang S; Qiu W; Pang M; Zeng X; Xu X; Yang Y; Yang B; Chu L
Brain Res; 2024 May; 1830():148796. PubMed ID: 38341169
[TBL] [Abstract][Full Text] [Related]
2. HSPA4 regulated glioma progression via activation of AKT signaling pathway.
Yuan X; Sun X; Zhou B; Zhao S; Li Y; Ming H
Biochem Cell Biol; 2024 Apr; 102(2):159-168. PubMed ID: 37339521
[TBL] [Abstract][Full Text] [Related]
3. 3'-UTR-mediated post-transcriptional regulation of cancer metastasis: beginning at the end.
Chaudhury A; Hussey GS; Howe PH
RNA Biol; 2011; 8(4):595-9. PubMed ID: 21654215
[TBL] [Abstract][Full Text] [Related]
4. NOTCH3 is a prognostic factor that promotes glioma cell proliferation, migration and invasion via activation of CCND1 and EGFR.
Alqudah MA; Agarwal S; Al-Keilani MS; Sibenaller ZA; Ryken TC; Assem M
PLoS One; 2013; 8(10):e77299. PubMed ID: 24143218
[TBL] [Abstract][Full Text] [Related]
5. EEF1D stabilized by SRSF9 promotes colorectal cancer via enhancing the proliferation and metastasis.
Wang R; Lv C; Li D; Song Y; Yan Z
Int J Cancer; 2024 May; ():. PubMed ID: 38771720
[TBL] [Abstract][Full Text] [Related]
6. PODNL1 promotes cell proliferation and migration in glioma via regulating Akt/mTOR pathway.
Geng Y; Zuo P; Li XO; Zhang L
J Cancer; 2020; 11(21):6234-6242. PubMed ID: 33033506
[No Abstract] [Full Text] [Related]
7. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against eukaryotic translation elongation factor 1 delta in two patients with autoimmune cerebellar ataxia.
Guo L; Ren H; Fan S; Chao X; Liu M; Guan H; Wang J
Front Immunol; 2023; 14():1289175. PubMed ID: 38332912
[TBL] [Abstract][Full Text] [Related]
9. TPPP3 promote epithelial-mesenchymal transition via Snail1 in glioblastoma.
Xu X; Hou Y; Long N; Jiang L; Yan Z; Xu Y; Lv Y; Xiang X; Yang H; Liu J; Qi X; Chu L
Sci Rep; 2023 Oct; 13(1):17960. PubMed ID: 37863960
[TBL] [Abstract][Full Text] [Related]
10. Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers.
Rabah N; Ait Mohand FE; Kravchenko-Balasha N
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762559
[TBL] [Abstract][Full Text] [Related]
11. Characterization of somatic mutations and pathway alterations during hepatocellular carcinoma vascular invasion using next-generation sequencing.
Li Q; Zhang Q; Chen J; Zang M; Hu X; Li R; Hou J; Zhou J
J Gastrointest Oncol; 2022 Aug; 13(4):1864-1874. PubMed ID: 36092348
[TBL] [Abstract][Full Text] [Related]
12. Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway.
Luo X; Wang J; Lu J; Wang X; Miao Y; Li Q; Li X; Wang L
Biomed Res Int; 2022; 2022():1874550. PubMed ID: 35757470
[TBL] [Abstract][Full Text] [Related]
13. Deoxyschizandrin Inhibits the Proliferation, Migration, and Invasion of Bladder Cancer Cells through ALOX5 Regulating PI3K-AKT Signaling Pathway.
Chi B; Sun Y; Zhao J; Guo Y
J Immunol Res; 2022; 2022():3079823. PubMed ID: 35664354
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Methionine Cycle Genes
Chen PM; Tsai CH; Huang CC; Hwang HH; Li JR; Liu CC; Ko HA; Chiang EI
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008908
[TBL] [Abstract][Full Text] [Related]
15. The role of EEF1D in disease pathogenesis: a narrative review.
Xu H; Yu S; Peng K; Gao L; Chen S; Shen Z; Han Z; Chen M; Lin J; Chen S; Kang M
Ann Transl Med; 2021 Oct; 9(20):1600. PubMed ID: 34790806
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective Effects of GV1001 in Animal Stroke Model and Neural Cells Subject to Oxygen-Glucose Deprivation/Reperfusion Injury.
Kwon HS; Kim YE; Park HH; Son JW; Choi H; Lee YJ; Kim HY; Lee KY; Koh SH
J Stroke; 2021 Sep; 23(3):420-436. PubMed ID: 34649386
[TBL] [Abstract][Full Text] [Related]
17. EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway.
Xie C; Zhou M; Lin J; Wu Z; Ding S; Luo J; Zhan Z; Cai Y; Xue S; Song Y
Biomed Res Int; 2020; 2020():7804706. PubMed ID: 33029523
[TBL] [Abstract][Full Text] [Related]
18. EEF1D modulates proliferation and epithelial-mesenchymal transition in oral squamous cell carcinoma.
Flores IL; Kawahara R; Miguel MC; Granato DC; Domingues RR; Macedo CC; Carnielli CM; Yokoo S; Rodrigues PC; Monteiro BV; Oliveira CE; Salmon CR; Nociti FH; Lopes MA; Santos-Silva A; Winck FV; Coletta RD; Paes Leme AF
Clin Sci (Lond); 2016 May; 130(10):785-99. PubMed ID: 26823560
[TBL] [Abstract][Full Text] [Related]
19. TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway.
Gao X; Jiang W; Ke Z; Huang Q; Chen L; Zhang G; Li C; Yu X
Biochem Biophys Res Commun; 2022 Jan; 586():34-41. PubMed ID: 34826698
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
